120,000 Shares in Church & Dwight Co., Inc. (NYSE:CHD) Acquired by Healthcare of Ontario Pension Plan Trust Fund

Healthcare of Ontario Pension Plan Trust Fund purchased a new position in shares of Church & Dwight Co., Inc. (NYSE:CHD) during the 3rd quarter, HoldingsChannel reports. The institutional investor purchased 120,000 shares of the company’s stock, valued at approximately $12,566,000.

Several other institutional investors and hedge funds have also bought and sold shares of CHD. Capital Performance Advisors LLP bought a new position in Church & Dwight during the 3rd quarter worth approximately $27,000. Ashton Thomas Securities LLC bought a new position in Church & Dwight during the 3rd quarter worth approximately $28,000. Rothschild Investment LLC bought a new stake in shares of Church & Dwight in the 2nd quarter worth approximately $31,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Church & Dwight in the 2nd quarter worth approximately $33,000. Finally, Strategic Financial Concepts LLC bought a new stake in shares of Church & Dwight in the 2nd quarter worth approximately $38,000. 86.60% of the stock is currently owned by institutional investors.

Church & Dwight Stock Performance

NYSE:CHD opened at $110.36 on Friday. The stock has a 50-day simple moving average of $104.73 and a two-hundred day simple moving average of $104.33. Church & Dwight Co., Inc. has a 52-week low of $90.26 and a 52-week high of $113.50. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.09 and a current ratio of 1.62. The firm has a market capitalization of $27.04 billion, a PE ratio of 49.49, a P/E/G ratio of 4.04 and a beta of 0.55.

Church & Dwight (NYSE:CHD) last announced its quarterly earnings data on Friday, November 1st. The company reported $0.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.68 by $0.11. Church & Dwight had a net margin of 9.08% and a return on equity of 19.90%. The business had revenue of $1.51 billion during the quarter, compared to analyst estimates of $1.50 billion. During the same period last year, the firm posted $0.74 EPS. The company’s revenue was up 3.8% on a year-over-year basis. Analysts forecast that Church & Dwight Co., Inc. will post 3.45 EPS for the current year.

Church & Dwight Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 2nd. Stockholders of record on Friday, November 15th will be issued a $0.2838 dividend. This represents a $1.14 annualized dividend and a dividend yield of 1.03%. The ex-dividend date is Friday, November 15th. Church & Dwight’s dividend payout ratio (DPR) is presently 50.67%.

Insider Transactions at Church & Dwight

In related news, CAO Joseph James Longo sold 7,780 shares of the company’s stock in a transaction on Friday, November 22nd. The shares were sold at an average price of $112.44, for a total transaction of $874,783.20. Following the sale, the chief accounting officer now owns 400 shares of the company’s stock, valued at $44,976. This represents a 95.11 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Matthew Farrell sold 165,823 shares of the company’s stock in a transaction on Monday, November 4th. The shares were sold at an average price of $103.03, for a total transaction of $17,084,743.69. Following the sale, the chief executive officer now directly owns 112,719 shares in the company, valued at approximately $11,613,438.57. The trade was a 59.53 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 543,513 shares of company stock valued at $56,795,253. 2.00% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Truist Financial cut their price objective on Church & Dwight from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Monday, August 5th. Deutsche Bank Aktiengesellschaft lifted their price objective on Church & Dwight from $114.00 to $115.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. Piper Sandler initiated coverage on Church & Dwight in a research report on Tuesday, September 24th. They set an “overweight” rating and a $120.00 price target on the stock. JPMorgan Chase & Co. lifted their price target on Church & Dwight from $98.00 to $99.00 and gave the company an “underweight” rating in a research report on Monday, November 4th. Finally, Wells Fargo & Company lifted their price target on Church & Dwight from $113.00 to $115.00 and gave the company an “overweight” rating in a research report on Monday, November 4th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat, Church & Dwight currently has a consensus rating of “Hold” and an average price target of $108.53.

About Church & Dwight

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.